<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2016061128392N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-07-01</date_registration>
      <primary_sponsor>National Nutrition &amp; Food Technology Research Institute (NNFTRI)</primary_sponsor>
      <public_title>Assessment of cinnamon effects in type 2 diabetic patients</public_title>
      <acronym></acronym>
      <scientific_title>Assessment of cinnamon effects on advanced glycation end products, plasma vascular and systematic inflammation factors, antioxidant status, NF-kB and Sirtuin1 activity in mononuclear cells in type 2 diabetic patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-03-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/23048</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>1-2</phase>
      <hc_freetext>DIABETES.</hc_freetext>
      <i_freetext>Intervention 1: The intervention group: capsules 1 gr Cinnamon, 3 times per day, for 8 weeks. Intervention 2: Control group: capsules 1 gr microcristalin cellulose, 3 times per day, for 8 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Behrouz Talaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>NO 7, St. shahid hafizi, West town, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 21 2236 0656</telephone>
        <email>B_TALAEI@HOTMAIL.COM</email>
        <affiliation>Shahid Beheshti University of Medical Sciences Faculty of Nutrition Sciences and food technology</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>dr.Parvin Mirmiran</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>NO 7, St. shahid hafizi, West Town, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 21 2236 0656</telephone>
        <email>B_TALAEI@HOTMAIL.COM , parvin.mirmiran@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion  criteria :  Having  type  2  diabetes  for  at least  10  years؛  FBS  &lt;180  and  2  h-blood-sugar  &lt;250  mg/dl؛  no pregnancy  or  lactation؛  no  autoimmune  disorder؛ without any thyroid , kidney , CVD diseases,  thyroid  and  chronic  inflammatory  diseases,  peptic  ulcer  and  infection؛  no  regular&#13;
consumption  of  cinnamon or  other  herbal  drugs؛  no  sensitivity&#13;
People who are just using the pills (not insulin)؛ your diabetes control cinnamon؛  body  mass  index  (BMI)  &lt;30  kg/m ؛ Age between 70-25 years.&#13;
 Exclusion  criteria :  No  observation  of  research  protocol  (no consumption  of  more  than  20%  of  the  capsules)؛ any  sensitivity  due  to  cinnamon consumption  reported  by  the patient  or  noticed  after  the  outset  of  the  study؛  consumption  of  alcohol  or  narcotic  drugs؛  and  any  variation in  patients’  routine  treatment  according  to  physicians’  resolution  (i.e.,  variation  in  type  and  dose  of  the  drugs  to  be consumed,  and  treatment  with  insulin)؛ Pregnancy during the study.</inclusion_criteria>
      <agemin>70 years</agemin>
      <agemax>25 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E11.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Non-insulin-dependent diabetes mellitus without complications</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The intervention group: capsules 1 gr Cinnamon, 3 times per day, for 8 weeks.</i_keyword>
      <i_keyword>Control group: capsules 1 gr microcristalin cellulose, 3 times per day, for 8 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sirtuin Activity 1. Timepoint: Before and after the intervention. Method of measurement: ng/ml.</prim_outcome>
      <prim_outcome>Fasting insulin. Timepoint: Before and after the intervention. Method of measurement: mU/L.</prim_outcome>
      <prim_outcome>HOMA-IR. Timepoint: Before and after the intervention. Method of measurement: %.</prim_outcome>
      <prim_outcome>Fasting plasma glucose. Timepoint: Before and after the intervention. Method of measurement: mg/dl.</prim_outcome>
      <prim_outcome>Carboxymethyl-lysine plasma. Timepoint: Before and after the intervention. Method of measurement: ng/ml.</prim_outcome>
      <prim_outcome>Hb A1c. Timepoint: Before and after the intervention. Method of measurement: %.</prim_outcome>
      <prim_outcome>The activity NF-kB. Timepoint: Before and after the intervention. Method of measurement: ng/ml.</prim_outcome>
      <prim_outcome>VCAM-1. Timepoint: Before and after the intervention. Method of measurement: ng/ml.</prim_outcome>
      <prim_outcome>Hs-CRP. Timepoint: Before and after the intervention. Method of measurement: ng/ml.</prim_outcome>
      <prim_outcome>IL-6. Timepoint: Before and after the intervention. Method of measurement: ng/L.</prim_outcome>
      <prim_outcome>TNF. Timepoint: Before and after the intervention. Method of measurement: ng/L.</prim_outcome>
      <prim_outcome>ICAM-1. Timepoint: Before and after the intervention. Method of measurement: ng/ml.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Vitamin E diet. Timepoint: Before and after the intervention. Method of measurement: mg/day.</sec_outcome>
      <sec_outcome>MUFA. Timepoint: Before and after the intervention. Method of measurement: gr/day.</sec_outcome>
      <sec_outcome>PUFA. Timepoint: Before and after the intervention. Method of measurement: gr/day.</sec_outcome>
      <sec_outcome>Salt diet. Timepoint: Before and after the intervention. Method of measurement: gr/day.</sec_outcome>
      <sec_outcome>SAFA. Timepoint: Before and after the intervention. Method of measurement: gr/day.</sec_outcome>
      <sec_outcome>Fat Diet. Timepoint: Before and after the intervention. Method of measurement: gr/day.</sec_outcome>
      <sec_outcome>Cholesterol diet. Timepoint: Before and after the intervention. Method of measurement: mg/day.</sec_outcome>
      <sec_outcome>Dietary fiber. Timepoint: Before and after the intervention. Method of measurement: mg/day.</sec_outcome>
      <sec_outcome>Protein Diet. Timepoint: Before and after the intervention. Method of measurement: gr/day.</sec_outcome>
      <sec_outcome>BMI. Timepoint: Before and after the intervention. Method of measurement: Kilograms per square meter.</sec_outcome>
      <sec_outcome>Carb Diet. Timepoint: Before and after the intervention. Method of measurement: gr/day.</sec_outcome>
      <sec_outcome>Total dietary energy. Timepoint: Before and after the intervention. Method of measurement: Kcal/day.</sec_outcome>
      <sec_outcome>Vitamin C diet. Timepoint: Before and after the intervention. Method of measurement: mg/day.</sec_outcome>
      <sec_outcome>Selenium diet. Timepoint: Before and after the intervention. Method of measurement: mcg/day.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name>Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences</sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>National Nutrition &amp; Food Technology Research Institute (NNFTRI)</source_name>
      <source_name>Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-03-12</approval_date>
        <contact_name>National Nutrition &amp; Food Technology Research Institute (NNFTRI)</contact_name>
        <contact_address>NO 7, St. shahid hafizi, West town, Tehran Tehran  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
